Abeona Therapeutics (ABEO) Other Non-Current Assets (2010 - 2026)

Abeona Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $827000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 1350.88% year-over-year to $827000.0; the TTM figure through Mar 2026 stood at $827000.0 (up 1350.88% YoY), while the FY2025 annual figure was $781000.0, up 713.54% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $827000.0, up from $781000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $5.3 million in Q3 2022, with the low at $20000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $338000.0 (2022), against an average of $573588.2.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets sank 98.27% in 2022, then jumped 1350.88% in 2026.
• Abeona Therapeutics' Other Non-Current Assets stood at $338000.0 in 2022, then dropped by 18.05% to $277000.0 in 2023, then tumbled by 65.34% to $96000.0 in 2024, then surged by 713.54% to $781000.0 in 2025, then grew by 5.89% to $827000.0 in 2026.
• Business Quant data shows ABEO's Other Non-Current Assets at $827000.0 in Q1 2026, $781000.0 in Q4 2025, and $338000.0 in Q3 2025.